A new study by the CDC found that starting Tamiflu upon hospital admission for flu patients significantly reduces the risk of death compared to delaying treatment. The study examined data from over 26,000 hospitalized flu patients, revealing a 40% higher mortality rate in those who started treatment two to five days after admission. This emphasizes the importance of early antiviral treatment for hospitalized flu patients.
New research reveals a ‘back door’ entryway some flu viruses use to infect cells, potentially increasing their ability to spread between species, raising concerns about future pandemics.
A new study suggests that applying Neosporin ointment to the inside of the nose may help protect against respiratory viruses like those that cause COVID-19 and the flu. The study found that Neosporin triggers an immune response that creates a barrier against viruses. However, more research is needed to confirm whether this approach is effective in preventing infections in humans.
Researchers have identified key barriers to vaccine uptake for whooping cough, flu, and Covid-19 in pregnant women. These barriers include concerns about safety, lack of knowledge, fear of adverse effects, and lack of endorsement from healthcare professionals. To address these barriers, researchers recommend focusing on “five Cs” – confidence, complacency, convenience, communication, and context. By implementing these recommendations in public health strategies, we can increase protection of mothers-to-be and their children.
